Introduction The unprecedented success of chimeric antigen receptor (CAR)-T-cell therapy
in the management of B-cell malignancies comes with a price of specific side effects. Healthy …

Clostridioides difficile is an increasingly common pathogen both within and outside the
hospital and is responsible for a large clinical spectrum from asymptomatic carriage to …

Background Chimeric antigen receptor (CAR)‐T‐cell therapies have revolutionized the
management of acute lymphoblastic leukemia, non‐Hodgkin lymphoma, and multiple myeloma …

Background This study aims to describe the epidemiology of COVID-19 patients in a Swiss
university hospital. Methods This retrospective observational study included all adult patients …

Background After mild COVID-19, some outpatients experience persistent symptoms. However,
data are scarce and prospective studies are urgently needed. Objectives To characterize …

Following the Swiss Federal Office of Public Health (FOPH) authorization of the rapid antigen
test (RAT), we implemented the use of the RAT in the emergency ward of our university …

Background. Coronavirus disease 2019 (COVID-19) can result in profound changes in blood
coagulation. The aim of the study was to determine the incidence and predictors of venous …

Background The epidemiology of cytomegalovirus (CMV) after chimeric antigen receptor–modified
T-cell immunotherapy (CARTx) is poorly understood owing to a lack of routine …

More than 3 years have passed since Coronavirus disease 2019 (COVID‐19) was declared
a global pandemic, yet COVID‐19 still severely impacts immunocompromised individuals …

Background Influenza infections have been associated with high morbidity. The aims were
to determine predictors of mortality among patients with influenza infections and to ascertain …